Login
Navigate Fool.com
Will JNJ beat
the market?

Johnson & Johnson

NYSE: JNJ

Community Rating: 5 Stars: The Best

88.09 0.64 (0.73%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $87.47
Previous Close $87.45
Daily Range $87.41 - $88.20
52-Week Range $61.71 - $88.20
Market Cap $247.4B
P/E Ratio 23.83
Dividend (Yield) $2.64 (3.0%)
Ex-Dividend Date
Dividend Pay Date
05/23/13
06/11/13
Volume 11,439,498
Average Daily Volume 9,680,519
Current FY EPS $5.41

How do you think JNJ
will perform against the market?

Top JNJ Bull/Bear Pitches

 

mtinvest (< 20)
Submitted December 2, 2011

Buffett has been selling, while he should be buying. I don't quite understand it, because he doesn't need the cash.

0 Replies Reply Report this Post
 

acegdl007 (< 20)
Submitted January 20, 2011

J&amp;J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been signi … More

2 Replies Reply Report this Post

News & Commentary Rss Feed

Will Obamacare Crush Medtronic's Earnings?

The medical-device maker reports earnings on Tuesday.

This 10-Stock Dividend Strategy Is Trouncing the Dow

The Dogs of the Dow are beating the Dow by 4% so far this year.

Abbott Laboratories Stock Checkup for May

With shares up by a double-digit percentage so far in 2013, how does Abbott Laboratories stock look now? Find out in this month's stock checkup.

J&J, Up 25% YTD, Shrugs Off Risperdal Suits

Good News For Health Care Stocks Part 2

Diagnosing Alzheimer's First

Small Is Beautiful: Now's the Time for Growth-Oriented Investors to Move Into Small-Cap Stocks

Portfolios focusing on low-volatility, high-quality small-cap stocks may be able to reduce overall portfolio volatility and achieve better returns.

Small Is Beautiful: Now's the Time for Growth-Oriented Investors to Move Into Small-Cap Stocks

Correction to Thursday's Johnson & Johnson-Metal-on-Metal Hip-Products Story

Johnson & Johnson to Discontinue Metal-on-Metal Hip Products

See More JNJ News...

Sector

Healthcare

Industry

Drugs

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website: http://www.jnj.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks